Jonathan Kay

Timothy S. and Elaine L. Peterson Chair in Rheumatology & Professor of Medicine

University of Massachusetts Chan Medical School

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jonathan Kay is the Timothy S. and Elaine L. Peterson Chair in Rheumatology and a Professor of Medicine at the University of Massachusetts Medical School, USA. His research focuses on disparities in diagnosis and treatment strategies for axial spondyloarthritis and rheumatoid arthritis. Recent publications explore topics such as the impact of sex differences on treatment initiation and the development of screening tools for axial spondyloarthritis. He is also involved in studies examining patient experiences with diagnostic delays and the efficacy of biologic therapies in rheumatologic conditions.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Catherine Dube

Associate Professor

University of Massachusetts Chan Medical School

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jonathan Kay

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Disparities in Diagnosis: A Call for Equity in Radiographic Axial Spondyloarthritis Care

American College of Rheumatology and Food and Drug Administration Summit: Summary of the Meeting, May 17–18, 2022

Sex Differences in Time to Initiate Nonsteroidal Anti‐Inflammatory Drugs or Biologic Disease‐Modifying Antirheumatic Drugs Among Patients With Axial Spondyloarthritis

Postpartum Depression in Reproductive-Age Women With and Without Rheumatic Disease: A Population-Based Matched Cohort Study

Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis

Development and test–retest reliability of a screening tool for axial spondyloarthritis

Personal Experiences with Diagnostic Delay Among Axial Spondyloarthritis Patients: A Qualitative Study

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

Physical Activity and Attitudes Toward Exercise in People With Axial and Peripheral Spondyloarthritis

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib

Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional Incentives

Examining Treatment Decision‐Making Among Patients With Axial Spondyloarthritis: Insights From a Conjoint Analysis Survey

Clinical trial and ‘real-world’ data support switching from a bio-originator to its biosimilar

Collaborators (1)

Catherine Dube

Make your next move.